Two Northwestern University scientists have identified a biomarker strongly associated with basal-like breast cancer, a highly aggressive carcinoma that is resistant to many types of chemotherapy. The biomarker, a protein called STAT3, provides a smart target for new therapeutics designed to treat this often deadly cancer.
I have been building forums to promote the life sciences community for over 10 years. I enjoy exploring the issues, individuals and companies impacting the life/med/health tech community, and celebrating the innovators, entrepreneurs and policy makers who are actively working to build the community.
Brain surgeons have long relied on a pathology analysis to determine if they have completely removed a tumor. This can be a time-consuming and inaccurate process. Results from a study of a new imaging system that detects a molecular biomarker found in brain gliomas suggest it could improve upon that surgical practice.
Pediatric devices are in short supply because of the prevalence of rare diseases in children, as well as their unique physiology. So, FDA’s 510(k) clearance of Medtronic’s ($MDT) Shillla Growth Guidance System for the treatment of scoliosis in children less than 10 years old has particular significance.
Last week I had to take WhiteCityDown because of some technical issues relating to the rapid growth. so I spent the long holiday weekend rebuilding the website. The news WhiteCityNews website is on a more robust platform with new features: Featured Posts Editorial Company Highlights Streamlined Navigation Improved Design Breaking News Ticker Article Review System WCN readership more…
Newly minted biopharma billionaire Liu Dianbo has added to his fortune while burnishing his rep as one of the top biotech drug developers in China. His company, Luye Pharma Group, acquired a 58% stake in Beijing Jialin Pharma Pharmaceutical for close to $600 million, beefing up its pipeline of cardiovascular drugs while expanding its product lineup.
For months now rumors of a big prospective biotech relocation have been circulating in the hot Boston hub. And now the Boston Business Journal, a weekly with its ear to the ground on all things related to real estate, reports that its sources are saying that the company in question is Baxter International ($BAX).